Reach Banner
Last name



This is a "connection" page, showing publications co-authored by Paul Nathan and Tal Schechter.

Connection Strength
  1. Schechter T, Pole JD, Darmawikarta D, Doyle J, Ali M, Egeler M, Gassas A, Irwin MS, Greenberg M, Nathan PC. Late mortality after hematopoietic SCT for a childhood malignancy. Bone Marrow Transplant. 2013 Oct; 48(10):1291-5.
    View in: PubMed
    Score: 0.600
  2. Pole JD, Darmawikarta D, Gassas A, Ali M, Egler M, Greenberg ML, Doyle J, Nathan PC, Schechter T. Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT. Bone Marrow Transplant. 2015 May; 50(5):721-6.
    View in: PubMed
    Score: 0.170
  3. Furzer J, Gupta S, Nathan PC, Schechter T, Pole JD, Krueger J, Pechlivanoglou P. Cost-effectiveness of Tisagenlecleucel vs Standard Care in High-risk Relapsed Pediatric Acute Lymphoblastic Leukemia in Canada. JAMA Oncol. 2020 Mar 01; 6(3):393-401.
    View in: PubMed
    Score: 0.060
  4. West SL, White G, Caterini JE, Rayner T, Schechter T, Nathan PC, Wells GD. Skeletal Muscle Dysfunction and Exercise Intolerance in Children Treated with Haematopoietic Stem Cell Transplant-A Pilot Feasibility Study. Int J Environ Res Public Health. 2019 05 08; 16(9).
    View in: PubMed
    Score: 0.057
  5. West SL, Gassas A, Schechter T, Egeler RM, Nathan PC, Wells GD. Exercise intolerance and the impact of physical activity in children treated with hematopoietic stem cell transplantation. Pediatr Exerc Sci. 2014 Aug; 26(3):358-64.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.